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Abstract: The vasodilatory effect of cinnamaldehyde was investigated for its mechanism of 
action using isolated rings of rat aorta. Cinnamaldehyde relaxed aortic rings precontracted with 
phenylephrine in a dose-dependent manner, was not affected by either the presence or removal of 
the endothelium. Pretreatment with NG-nitro-L-arginine methyl ester and 1H-[1,2,4]-oxadiazole-
[4,3-a]-quinoxalin-1-one could not block vasodilation by   cinnamaldehyde, indicating that nitric 
oxide signaling is not involved. Potassium channel   blockers, such as glibenclamide, tetraethylam-
monium, and BaCl2, had no effect on the   relaxation produced by cinnamaldehyde. In addition, 
treatment with either indomethacin or propranolol did not affect   cinnamaldehyde-induced 
vasodilatation. On the other hand, pretreatment of endothelium-denuded rings with cinna-
maldehyde significantly inhibited vasoconstriction induced by endogenous vasoconstrictors, 
including angiotensin II, 5-hydroxytryptamine, dopamine, endothelin-1, and phenylephrine. In 
a Ca2+-free experimental setting, this natural vasodilator not only blocked Ca2+ influx-dependent 
vasoconstriction by either phenylephrine or KCl, but also inhibited phenylephrine-induced 
tonic contraction, which relies on intracellular Ca2+ release. This study shows that endothelium-
independent, Ca2+ influx and/or an inhibitory release mechanism contributes to the vasodilatory 
effect of cinnamaldehyde.
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Introduction
Cinnamomum cassia is a Chinese herbal medicine frequently used for its multiple 
  therapeutic functions, such as enhancing immunity, eliminating the sense of cold-
ness, relieving pain and improving blood circulation.1 In modern pharmacological 
research, C. cassia has exhibited diverse actions, including antioxidative stress,2 
  preventing mitochondrial dysfunction,3 antitumor properties,4 and inhibition of 
tau protein aggregation in Alzheimer’s disease.5 Cinnamaldehyde, one of the main 
constituents of C. cassia, is an aromatic aldehyde which has been reported to have 
multiple potential therapeutic activities.6 Ma et al found that cinnamaldehyde could 
decrease production of prostaglandin E2 stimulated by interleukin-1β and could 
downregulate the expression of transient receptor potential vanilloid subtype 4 in 
the cerebral microvascular endothelial cells of the mouse, which may contribute to 
its antipyretic effects.7 Chao et al has reported that cinnamaldehyde has antioxidant 
and anti-inflammatory properties. Low concentrations of cinnamaldehyde can inhibit 
secretion of interleukin-1β, tumor necrosis factor α, and reduce reactive oxygen 
  species in lipopolysaccharide-stimulated J774 A.1   macrophages. The phosphorylation 
of extracellular signal-regulated kinase 1/2 and c-Jun N-terminal kinase 1/2 induced   Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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by lipopolysaccharides was also inhibited.8 In addition, 
Liao et al found that cinnamaldehyde inhibits adhesion of 
tumor necrosis factor α-induced monocytes to endothelial 
cells, and suppresses the expression of vascular cell adhe-
sion molecule-1 and intercellular adhesion molecule-1 at 
the transcriptional level by suppressing nuclear transcription 
factor κB activation.9
With regard to the circulation, several studies have shown 
that cinnamaldehyde has antiplatelet and antithrombotic 
activity.10,11 In anesthetized rats, cinnamaldehyde decreased 
blood pressure, left ventricular systolic pressure, and rate of 
change of left ventricular maximum pressure (dp/dtmax).12 
Cinnamaldehyde also showed a dose-dependent relaxation 
of the rat aorta contraction induced by noradrenaline, potas-
sium, and prostaglandin F2α.12,13 Based on the above obser-
vations, we hypothesized that the   cardiovascular effect of 
cinnamaldehyde may be due to signaling beyond the recep-
tor level. In the present study, we systematically evaluated 
the vasodilatory effects of cinnamaldehyde in isolated rat 
aorta rings using pharmacological methods and explored its 
potential mechanism of action.
Methods and materials
Reagents
Cinnamaldehyde (C9H8O, Figure 1) was purchased from 
Aladdinbiotech Company (Shanghai, China).   Acetylcholine, 
phenylephrine, NG-nitro-L-arginine methyl ester (L-NAME), 
1H-[1,2,4]-oxadiazole-[4,3-a]-quinoxalin-1-one (ODQ), 
indomethacin, propranolol, glibenclamide, tetraethylammo-
nium, BaCl2, angiotensin II, 5-hydroxytryptamine, dopamine, 
and endothelin-1 were purchased from Sigma Chemical Co 
(St Louis, MO). Ethyleneglycol bis   (2-aminoethyl ether) 
tetra-acetic acid (EGTA) and other inorganic salts were 
all purchased from Sinopharm Chemical Reagent Co 
Ltd (Shanghai, China). Acetylcholine, phenylephrine, 
L-NAME, tetraethylammonium, propranolol, angiotensin II, 
  5-hydroxytryptamine, dopamine, and endothelin-1 were 
dissolved in distilled water; indomethacin, glibenclamide, 
and ODQ were dissolved in dimethyl sulfoxide. Control 
experiments had demonstrated that the highest dimethyl 
sulfoxide level (1:400) had no effect on vascular tone.
Animals and vascular ring preparation
Male Sprague-Dawley rats weighing 250 to 300 g were 
purchased from the Shanghai Experimental Animal Center 
of Academia Sinica and used for all experiments. Animals 
were handled and cared in compliance with the Guide for the 
Care and Use of Laboratory Animals (Shanghai University 
of Tradition Chinese Medicine).
The rats were killed by cervical dislocation and their 
  thoracic aortas were rapidly removed and dissected in 
ice-cold Krebs solution (pH 7.4, containing [mM] NaCl 118, 
KCl 4.7, MgSO4 1.1, KH2PO4 1.2, CaCl2 1.5, NaHCO3 25, 
and glucose 10). The aortas were cut into 3 mm-wide ring 
segments after removing the surrounding connective tissue 
and fat. All dissection procedures were done with extreme 
care to protect the endothelium from inadvertent damage. 
In some aortic rings, the endothelial layer was mechani-
cally removed by gently rubbing the luminal surface of the 
aortic ring back and forth several times with a wooden tooth 
pick. Each ring was suspended with two L-shaped stainless 
steel wires in a 4 mL organ bath filled with Krebs solution 
and maintained at 37°C. The upper wire was connected to 
a force displacement transducer (Grass Instruments, West 
Warwick, RI) and the lower one fixed at the bottom of the 
organ bath. The bath solution was continuously bubbled 
with 95% O2 and 5% CO2. The baseline load placed on the 
aortic ring was 2.0 g.
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Figure 1 A) The Cinnamomum cassia plant. B) The chemical structure of cinnamaldehyde.Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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examination of endothelial integrity
At the beginning of each experiment, the bath solution was 
replaced every 20 minutes with prewarmed and oxygenated 
Krebs solution. After equilibrating for 60 minutes, all aortic 
rings were contracted twice with KCl 60 mM to obtain a 
maximal response, and the rings were washed three times 
at 20-minute intervals with Krebs solution. After   restoration 
of vessel tension to baseline levels, the rings were exposed 
to phenylephrine 10−6 M to test their contractile responses, 
and subsequently challenged with acetylcholine to verify 
endothelial integrity or functional removal. Thus, the 
endothelium was considered intact when 15%–20% relax-
ation (percentage of 10−6 M forskolin-evoked relaxation) 
was achieved by   acetylcholine 10−7 M, 60% by acetylcholine 
10−6 M, and .80% by acetylcholine 10−5 M in aorta rings pre-
contracted using phenylephrine. When the endothelium was 
fully removed, ,1% relaxation in response to   acetylcholine 
10−5 M could be recorded (Figure 2).
Vasodilation by cinnamaldehyde
The vasodilatory effect of cinnamaldehyde was tested in 
both endothelium-intact and endothelium-denuded rings 
contracted with phenylephrine 10−6 M. Once a plateau of 
phenylephrine contraction was obtained, cinnamaldehyde 
was applied cumulatively at concentrations of 10−7, 10−6, 
10−5, and 10−4 g/mL. At the end of experiment, the relaxation 
induced by forskolin 10−6 M was recorded and used as 100% 
for blood vessel relaxation.
To understand the mechanisms of relaxation, L-NAME 
(a nitric oxide synthase inhibitor) and indomethacin 
(a cyclo-oxygenase inhibitor) were preincubated with an 
endothelium-intact ring for 25 minutes, and cinnamal-
dehyde-induced relaxation was observed. Preparations 
without endothelium were pretreated for 25 minutes with 
ODQ (a soluble guanylyl cyclase inhibitor), propranolol 
(an adrenergic β-receptor inhibitor), glibenclamide, (a KATP 
blocker), tetraethylammonium (a KCa blocker), and BaCl2 
(a KIR blocker) prior to addition of phenylephrine 10−6 M. 
Concentration-dependent vasodilation by cinnamaldehyde 
was then examined.
effect of cinnamaldehyde  
on vasoconstriction
The endothelium-denuded ring was first contracted in a 
concentration-dependent manner by a series of constrictors, 
including dopamine, 5-hydroxytryptamine, angiotensin II, K+, 
endothelin-1, and phenylephrine. After washing, the ring 
was incubated with cinnamaldehyde 1.3 × 10−5 g/mL or 
5 × 10−5 g/mL for 10 minutes, and the contractions induced 
by the vasoconstrictors were again observed. The response 
to 60 mM K+ was used as 100% contraction.
Effect of cinnamaldehyde calcium influx
The aorta ring without endothelium was washed and treated 
with Ca2+-free high-K+ solution (containing 10−4 M EGTA and 
60 mM KCl). The Ca2+-free incubated media preparation was 
then cumulatively contracted with CaCl2 at concentrations in 
the range 0.5–3.0 mM. The contractions induced by CaCl2 
were compared between the group treated with cinnamalde-
hyde 1.3 × 10−5 g/mL and the controls.   Contraction induced 
by 60 mM K+ in normal Ca2+ media was used as 100%.
effect of cinnamaldehyde on calcium 
release
The endothelium-denuded ring was washed and exposed to Ca2+-
free Krebs solution (containing 10−4 M EGTA) for 20 minutes. 
Phenylephrine 10−6 M was added and a small tonic contraction 
mainly due to the release of intracellular Ca2+ was observed. 
Comparison between the group treated with cinnamaldehyde 
1.3 × 10−5 g/mL and the controls was made, with contraction 
by 60 mM K+ in normal Ca2+ media used as 100%.
statistical analysis
All data were expressed as means ± standard error, and 
analyzed using one-way analysis of variance. P , 0.05 was 
used as the significance level for statistical tests.
Results
cinnamaldehyde-induced relaxation
Despite a significant difference in acetylcholine-induced 
relaxation in aorta ring tissue with or without endothelium 
(Figure 2), cinnamaldehyde relaxed the blood vessels in an 
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Figure  2  concentration-response  curves  showing  dilation  by  acetylcholine 
of  endothelium-intact  and  endothelium-denuded  rings.  Acetylcholine  induced 
endothelium-dependent  relaxation  at  the  indicated  dose  in  phenylephrine 
precontracted rat aortic rings (n = 6).Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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endothelium-independent manner. Maximum relaxation of 
the vessel with and without endothelium by cinnamalde-
hyde was 86.78% and 85.71%, respectively, and the EC50 
was 1.16 × 10−5 g/mL and 1.32 × 10−5 g/mL, respectively 
(Figure 3A).
To verify further the involvement of nitric oxide/cyclic 
guanosine monophosphate signaling pathway, we pretreated 
endothelium-intact aortic rings with L-NAME 10−4 M or 
ODQ 10−5 M. Neither the nitric oxide synthase inhibitor nor 
the soluble guanylyl cyclase blocker affected cinnamalde-
hyde-induced vasodilation (Figures 3B and 3C).
To understand the involvement of the cyclooxygenase/
prostaglandin I2 pathway, indomethacin 10−5 M was used. 
The relaxation curve for cinnamaldehyde was not affected 
by indomethacin (Figure 3B).
effect of cinnamaldehyde on potassium 
channels and β-receptors
To test for possible involvement of K+ channels in 
  cinnamaldehyde-induced relaxation, we preincubated 
endothelium-denuded rings with tetraethylammonium 
3 × 10−3 M, BaCl2 10−4 M, and glibenclamide 10−5 M, each 
for 25 minutes. Tetraethylammonium (Figure 4A), BaCl2 
(Figure 4B), and glibenclamide (Figure 4C) did not inhibit 
vascular relaxation by cinnamaldehyde. We also used pro-
pranolol 10−5 M to preincubate the endothelium-denuded 
rings, which did not inhibit vascular relaxation induced by 
cinnamaldehyde (Figure 4D).
effect of cinnamaldehyde on endogenous 
vasoconstrictors
Dopamine, 5-hydroxytryptamine, angiotensin II,   endothelin-1, 
and phenylephrine are all endogenous vasoconstrictors and 
play key roles in vascular tone. We wondered whether cinna-
maldehyde relaxes blood vessel by blocking one of the above 
vasoconstrictors. We pretreated endothelium-denuded aorta 
rings with cinnamaldehyde at 1.3 × 10−5 g/mL (EC50 relax-
ation by cinnamaldehyde) and 5.0 × 10−5 g/mL, and found that 
cinnamaldehyde exerted inhibitory effects on the contrac-
tion curves of dopamine (Figure 5A),   5-hydroxytryptamine 
(Figure 5B), angiotensin II (  Figure 5C), and endothelin-1 
(Figure 5D), and phenylephrine (Figure 5E).
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Figure 3 Dose-dependent vasodilatory effect of cinnamaldehyde on rat aorta rings. cinnamaldehyde dilated both endothelium-intact and endothelium-denuded rings 
precontracted with phenylephrine, in a dose-dependent manner. The effect of cinnamaldehyde on this dilation was not different between the two groups (A, n = 6). 
endothelium-intact rings preincubated with ng-nitro-L-arginine methyl ester (L-nAMe) 10−4 M or indomethacin 10–5 M did not affect cinnamaldehyde function (B, n = 6). 
endothelium-denuded rings preincubated with 1H-[1,2,4]-oxadiazole-[4,3-a]-quinoxalin-1-one (ODQ) 10−5 M did not inhibit the effects of cinnamaldehyde (C, n = 6).Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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effect of cinnamaldehyde on calcium 
influx or release
Phenylephrine contracts vascular smooth muscle mainly 
by activation of receptor-operated Ca2+ channels, while 
KC1 mainly activates potential-dependent Ca2+ chan-
nels, all of which result in calcium influx.14 In this study, 
cinnamaldehyde pretreatment significantly reduced 
vasoconstriction by phenylephrine (Figure 5E) and KC1 
(Figure 6B).
To confirm the aforementioned observations, we tested the 
inhibitory effect of cinnamaldehyde on K+-stimulated volt-
age-dependent Ca2+ influx during a Ca2+-free experiment.14 As 
demonstrated in Figure 6A, Ca2+-induced vasoconstrictions 
stimulated by K+ 60 mM were significantly suppressed by 
pretreatment with cinnamaldehyde 1.3 × 10−5 g/mL.
When aorta rings were exposed to Ca2+-free media, addi-
tion of phenylephrine 10−6 M elicited a small tonic contraction 
induced mainly by intracellular Ca2+ release from endoplasmic 
reticulum stores.15 Pretreatment of   endothelium-denuded rings 
with cinnamaldehyde 5.0 × 10−5 g/mL   significantly reduced 
phenylephrine-induced contraction under   extracellular 
Ca2+-free conditions (Figure 6C).
Discussion
Vascular endothelium plays a key role in maintaining nor-
mal function of the vasculature.15 Endothelial cells release 
endothelium-dependent vasodilators, such as nitric oxide 
and prostacyclin (prostaglandin I2), upon stimulation of 
various factors in the blood stream and as a result of physi-
ological stress.15,16 Nitric oxide is mainly formed by nitric 
oxide synthase using L-arginine as a substrate. Diffusible 
nitric oxide gas penetrates vascular smooth muscle and 
activates soluble guanylyl cyclase which catalyzes guanos-
ine triphosphate to form cyclic guanosine monophosphate. 
Cyclic guanosine monophosphate-activated protein kinase 
G inhibits the Ca2+ influx, reduces sensitivity of contractile 
elements to Ca2+, and relaxes the blood vessel.14 In our 
study, cinnamaldehyde-induced vasodilation was neither 
affected by removal of endothelium nor by treatment with 
L-NAME (Figure 3B) or ODQ (Figure 3C). These results 
suggest that the vasodilatory effect of cinnamaldehyde is 
not mediated through the nitric oxide/cyclic guanosine 
monophosphate pathway. The   cyclo-oxygenase in either 
endothelial or smooth muscle cells can catalyze arachidonic 
acid to endoperoxide   prostaglandin H2, which is finally     
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Figure 4 effect of cinnamaldehyde on K+ channels and the β-receptor. After preincubation with tetraethylammonium 3 × 10−3 M, Bacl2 10−4 M, or glibenclamide 10−5 M 
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converted into prostacyclin, which   activates adenylyl cyclase 
and elevates cyclic adenosine monophosphate levels to 
relax the blood vessel.18 In the current study, relaxation by 
cinnamaldehyde in endothelium-intact aortic rings was not 
affected by indomethacin (Figure 3B), which rules out the 
involvement of the cyclo-oxygenase pathway.
Potassium channels regulate vascular smooth muscle tone 
by interfering with the cellular membrane potential.19 When 
the K+ channel is activated, an efflux of K+ causes membrane 
hyperpolarization, which reduces calcium influx and attenu-
ates vascular tone.19 At least four types of K+ channels were 
identified in arterial smooth muscle cells, ie, the voltage-
dependent K+ (KV) channel, activated by   depolarizing 
stimuli; the Ca2+-activated K+ (KCa) channel which responds 
to intracellular Ca2+; the inward rectifier K+ (KIR) channel 
which may be responsible for external K+-induced dilation; 
and the adenosine triphosphate-sensitive K+ (KATP) channel 
which responds to changes in adenosine triphosphate levels. 
It is known that Ba2+ and tetraethylammonium antagonize 
a broad range of K+ channels, and glibenclamide can block 
KATP.20 To test for possible involvement of K+ channels 
in cinnamaldehyde-induced relaxation, we preincubated 
vessel preparations with tetraethylammonium 3 × 10−3 M 
 ( Figure 4A), BaCl2 10−4 M (Figure 4B), and glibenclamide 
10−5 M (Figure 4C). We found that potassium channel block-
ers did not affect cinnamaldehyde-induced vasorelaxation.
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The adrenergic β-receptor is an important contributor 
to vasodilation by increasing intracellular cyclic adenosine 
monophosphate and activating protein kinase A.21 However, 
in our study, propranolol 10−5 M had no effect on cinnam-
aldehyde (Figure 4D), suggesting that vasodilation is not 
mediated via the adrenergic β-receptor.
Endogenous vasoconstrictors not only play a key role in 
maintaining vascular tension, but also serve as therapeutic 
targets in many pathological conditions, such as hypertension. 
Blood vessels pretreated with cinnamaldehyde attenuated vaso-
constriction by dopamine (Figure 5A), 5-hydroxytryptamine 
(Figure 5B), angiotensin II (Figure 5C), endothelin-1 
(Figure 5D), and phenylephrine (Figure 5E) in a concentration-
dependent manner. Thus, the involvement of a secondary sig-
naling pathway beyond specific receptor levels is speculated. 
It has been shown that adrenalin, angiotensin, endothelin-1, 
and 5-hydroxytryptamine all have G protein-coupled recep-
tors which can manipulate the intracellular Ca2+ concentration 
by interference with either Ca2+ influx or intracellular Ca2+ 
release.22 Indeed, calcium channels appear to play a crucial 
role in contraction of vascular smooth muscle.20,23
Intracellular Ca2+ controls smooth muscle contrac-
tion through binding with calmodulin to form a calcium-
  calmodulin complex. This complex further activates myosin 
light chain kinase to phosphorylate myosin light chains and 
cause muscle contraction.24 The intracellular Ca2+ concen-
tration can be regulated by extracellular Ca2+ influx through 
both the voltage-dependent Ca2+ channel and the receptor-
operated Ca2+ channel, or by intracellular Ca2+ release from 
endoplasmic reticulum Ca2+ stores.15 KCl mainly activates 
potential-dependent Ca2+ channels to promote calcium influx 
and vasoconstriction. In our study, cinnamaldehyde markedly 
inhibited CaCl2-induced contraction of vessels treated with 
Ca2+-free high-K+ media (Figure 6A). In addition, cinnam-
aldehyde also inhibited concentration-dependent contraction 
by K+ (Figure 6B). Thus, at least, Ca2+ influx through voltage-
sensitive Ca2+ channels is affected by cinnamaldehyde.
On the other hand, phenylephrine regulates intracellular 
Ca2+ through both receptor-operated calcium channels 
and intracellular Ca2+ release. As showed in Figure 5E, 
pretreatment with cinnamaldehyde significantly reduced 
phenylephrine contraction, suggesting possible interference 
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with Ca2+ influx through receptor-operated calcium channels. 
Furthermore, cinnamaldehyde also markedly inhibited small 
tonic contractions elicited by phenylephrine in Ca2+-free 
media-treated rings (Figure 6C), indicating a blockage of 
intracellular Ca2+ release. Taken together, we propose that 
cinnamaldehyde relaxes the isolated rat aorta by inhibiting 
both Ca2+ influx and Ca2+ release. However, further experi-
mentation with patch clamp methods is needed to confirm 
this mechanism in detail.
In conclusion, the present study demonstrates that 
cinnamaldehyde dilates vascular smooth muscle in an 
endothelium-independent manner. The vasodilatory effect 
of cinnamaldehyde may be related to its ability to interfere 
with both Ca2+ influx and Ca2+ release.
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